Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 131.22%10.78M | -321.93%-2.73M | 99.23%-330.81K | -68.86%6.13M | -73.09%7.71M | -34.14%4.66M | 90.83%-646.84K | -524.23%-43.03M | 203.29%19.69M | 1,244.75%28.64M |
Net income from continuing operations | -50.71%5.51M | -89.27%997.46K | 75.16%-18.74M | -97.97%1.13M | 0.77%22.13M | 61.58%11.18M | 151.87%9.3M | -514.88%-75.46M | 921.05%55.38M | 1,680.77%21.96M |
Operating gains losses | 100.03%2.37K | --0 | --19.56M | --770 | ---19.56M | ---8.23M | ---- | ---- | ---- | ---- |
Depreciation and amortization | 45.67%4.9M | 11.98%1.31M | 177.79%1.24M | -32.78%1.16M | -42.03%1.19M | 139.45%3.36M | 128.98%1.17M | -185.08%-1.59M | -1.84%1.73M | 13.63%2.06M |
Other non cash items | -41.11%-1.48M | -1,131.22%-382.31K | -253.94%-375.1K | -6.46%-143.47K | 51.34%-582.63K | ---1.05M | --37.07K | 145.51%243.66K | 71.52%-134.76K | -3,808.72%-1.2M |
Change In working capital | -88.85%-3.55M | -36.13%-5.66M | 45.08%-3.74M | -21.39%2.57M | -43.60%3.29M | -50.80%-1.88M | -138.82%-4.16M | -10.66%-6.81M | 1,587.70%3.27M | 204.45%5.82M |
-Change in receivables | 232.40%961.65K | 202.02%120.25K | 59.48%-2.6M | 36.89%1.58M | -59.93%1.87M | -204.77%-726.35K | -102.09%-117.87K | -1,292.85%-6.43M | 316.08%1.15M | 195.56%4.67M |
-Change in inventory | -1,493.77%-22.27K | -97.35%12.35K | 79.67%-81.35K | 641.17%206.55K | -456.52%-159.82K | 98.18%-1.4K | -62.78%465.64K | -125.06%-400.15K | 94.36%-38.17K | 98.72%-28.72K |
-Change in prepaid assets | 235.49%820.53K | 149.71%78.86K | 93.77%-223.61K | -94.64%156.92K | 272.68%808.37K | -27,438.88%-605.58K | -112.73%-158.64K | -22,265.37%-3.59M | 1,199.60%2.93M | 121.74%216.9K |
-Change in payables and accrued expense | -126.81%-417.88K | 88.23%-168.68K | 245.59%1.16M | -120.84%-484.14K | -163.28%-928.32K | 209.95%1.56M | 64.55%-1.43M | -135.25%-798.99K | 576.00%2.32M | -24.17%1.47M |
-Change in other working capital | -132.42%-4.89M | -95.73%-5.7M | -145.33%-2M | 135.94%1.11M | 440.67%1.69M | -47.00%-2.1M | -144.05%-2.91M | 146.00%4.4M | -439.70%-3.1M | -180.39%-497.51K |
Cash from discontinued investing activities | -92.65%3.78M | -96.39%253.28K | 49.35%51.46M | 7.02M | ||||||
Operating cash flow | -74.05%14.56M | -138.85%-2.48M | 125.93%3.2M | -68.86%6.13M | -73.09%7.71M | 35.12%56.13M | -76.74%6.37M | -86.04%1.42M | 203.29%19.69M | 1,244.75%28.64M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -47.63%-155.05M | -988.47%-152.12M | 78.42%-32.39M | -110.69%-3M | 17,981.99%32.46M | -35,419.45%-105.03M | 240.88%17.12M | -1,316.59%-150.08M | 18,671.03%28.12M | 44.63%-181.5K |
Net PPE purchase and sale | 99.78%-119.3K | -100.03%-4.7K | 67.46%-32.57M | --0 | 17,981.99%32.46M | -18,509.97%-55.03M | 240.88%17.12M | -911.28%-100.08M | 18,671.03%28.12M | 44.63%-181.5K |
Net investment purchase and sale | ---4.93M | ---2.11M | --181.1K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net other investing changes | -200.00%-150M | ---- | ---- | ---- | ---- | ---50M | --0 | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -341.72%-122.57M | -420.47%-152.12M | 100.40%99.11K | -110.69%-3M | 17,981.99%32.46M | 330.13%50.71M | 69,317.60%47.47M | -300.17%-24.69M | 18,671.03%28.12M | 44.63%-181.5K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -135.95%-5.13M | 74.94%-350K | -20.53%4.91M | -102.80%-350K | -207.74%-9.34M | 205.98%14.27M | 87.15%-1.4M | 460.25%6.17M | 894.32%12.52M | -43.25%-3.03M |
Net issuance payments of debt | ---- | ---- | ---- | --0 | -678.84%-5.26M | ---- | ---- | ---- | -681.76%-6.65M | 20.59%-675K |
Net common stock issuance | -121.18%-3.73M | --0 | --0 | --0 | ---3.73M | --17.6M | ---1.05M | ---767.77K | --19.42M | --0 |
Net preferred stock issuance | --0 | --0 | --0 | --0 | --0 | --40 | --0 | --0 | --0 | --40 |
Cash dividends paid | -64.38%-1.4M | 0.00%-350K | 0.00%-350K | -130.77%-350K | ---350K | ---851.67K | ---350K | ---350K | ---151.67K | --0 |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | 81.56%-2.48M | --0 | -101.55%-27.6K | 86.71%-96.54K | -86.07%-2.36M |
Cash from discontinued financing activities | 34.23%-5.26M | 0 | -162.06%-7.99M | -336.4K | ||||||
Financing cash flow | -265.55%-10.39M | 79.81%-350K | 76.38%-350K | -102.80%-350K | -207.74%-9.34M | 138.00%6.27M | 87.55%-1.73M | -234.45%-1.48M | 894.32%12.52M | -43.25%-3.03M |
Net cash flow | ||||||||||
Beginning cash position | 266.26%155.59M | 85.68%192.14M | 47.53%189.19M | 174.51%186.41M | 266.26%155.59M | 650.07%42.48M | 256.05%103.48M | 2,239.30%128.24M | 9,384.23%67.91M | 650.07%42.48M |
Current changes in cash | -204.67%-118.39M | -397.36%-154.94M | 111.91%2.95M | -95.39%2.78M | 21.24%30.83M | 207.22%113.11M | 288.37%52.11M | -205.00%-24.76M | 1,165.91%60.33M | 613.95%25.43M |
End cash Position | -76.09%37.2M | -76.09%37.2M | 85.68%192.14M | 47.53%189.19M | 174.51%186.41M | 266.26%155.59M | 266.26%155.59M | 256.05%103.48M | 2,239.30%128.24M | 9,384.23%67.91M |
Free cash flow | 189.76%14.44M | -139.34%-2.48M | 110.55%3.12M | 128.81%6.13M | -73.04%7.67M | -139.02%-16.09M | -77.40%6.3M | -400.52%-29.56M | -435.72%-21.29M | 1,105.73%28.46M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |